These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4976352)

  • 1. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors.
    Veenema RJ; Dean AL; Uson AC; Roberts M; Longo F
    J Urol; 1969 May; 101(5):711-5. PubMed ID: 4976352
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for bladder cancer.
    Veenema RJ; Romas NA; Fingerhut B
    Urology; 1974 Feb; 3(2):135-9. PubMed ID: 4204755
    [No Abstract]   [Full Text] [Related]  

  • 3. Thiotepa-induced myelosuppression: review of 670 bladder instillations.
    Soloway MS; Ford KS
    J Urol; 1983 Nov; 130(5):889-91. PubMed ID: 6415297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical thiotepa prophylaxis of superficial bladder cancer. A follow-up study.
    Fosså SD; Miller A; Stenwig AE
    Eur Urol; 1983; 9(4):207-10. PubMed ID: 6409615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer. An MRC Study. MRC Working Party on Urological Cancer.
    Br J Urol; 1985 Dec; 57(6):680-5. PubMed ID: 2867800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The harmfulness of intravesical instillations of thiotepa in cases of vesico-renal reflux].
    Rampal M; Alimi JC; Pons G; Fiquet JM
    J Urol Nephrol (Paris); 1978 Mar; 84(3):271-4. PubMed ID: 417193
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder].
    Toulouse J; Bouffier B; Etievent JP; Bittard M
    J Urol (Paris); 1983; 89(2):85-9. PubMed ID: 6408192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiotepa versus adriamycin versus cis-platinum in the intravesical prophylaxis of superficial bladder tumors.
    Llopis B; Gallego J; Mompó JA; Boronat F; Jiménez JF
    Eur Urol; 1985; 11(2):73-8. PubMed ID: 3924624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group.
    Koontz WW; Heney NM; Soloway MS; Kluskens L; Hazra TA; Trump DL; Barton B
    Urology; 1985 Oct; 26(4 Suppl):30-1. PubMed ID: 3931326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytostatic prophylactic treatment of superficial bladder tumours].
    Lunglmayr G
    Urologe A; 1972 Mar; 11(2):94-7. PubMed ID: 4623214
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in superficial neoplasms of the bladder.
    Zingg E; Sulmoni A
    S Afr Med J; 1972 Jul; 46(27):916-7. PubMed ID: 4626807
    [No Abstract]   [Full Text] [Related]  

  • 13. Intracavitary chemotherapy for multiple non-invasive bladder tumours.
    Riddle PR; Wallace DM
    Br J Urol; 1971 Apr; 43(2):181-4. PubMed ID: 4996213
    [No Abstract]   [Full Text] [Related]  

  • 14. The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report.
    Hisazumi H; Uchibayashi T; Naito K; Misaki T; Miyazaki K
    J Urol; 1975 Sep; 114(3):394-8. PubMed ID: 806708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical thiotepa in prevention of recurrence of bladder tumour.
    Ghosal SK; Sen DK
    J Indian Med Assoc; 1980 Nov; 75(9):173-4. PubMed ID: 6785360
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of topical THIOTEPA on the recurrence rate of superficial bladder cancers.
    Drew JE; Marshall VF
    J Urol; 1968 Jun; 99(6):740-3. PubMed ID: 4968248
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of thiotepa instillations in bladder cancer.
    Veenema RJ
    JAMA; 1968 Dec; 206(12):2725-6. PubMed ID: 4972303
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical chemotherapy and chemoprevention of superficial, low grade, low stage bladder carcinoma.
    Koontz WW
    Semin Oncol; 1979 Jun; 6(2):217-9. PubMed ID: 113878
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preventive value of intravesical thiotepa on the recurrence of Ta-T1 vesical tumors treated by conservative surgery. Apropos of 247 cases a mean follow-up of 88 months].
    Gilloz A; Sauvage I; Gremillet E; Héritier P; Richard A; el Hajj E; Diez-Yanguas J
    J Urol (Paris); 1987; 93(4):197-202. PubMed ID: 3119728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.